Application of LC-MS/MS Method for Evaluating Rosuvastatin Affinity with OATP1B1 and OATP2B1 in vitro

被引:1
|
作者
Zhang, Zhi-Yu [1 ,2 ]
Li, Quan-Sheng [2 ]
Si, Duan-Yun [2 ]
Yi, Xiu-Lin [2 ]
Liu, Chang-Xiao [2 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin 300193, Peoples R China
关键词
LC/MS/MS; Transporter; Rosuvastatin; OATP1B1; OATP2B1; HUMAN PLASMA; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HEPATIC-UPTAKE; TRANSPORTERS; QUANTIFICATION; DRUG; PHARMACOKINETICS; ACID; HPLC;
D O I
10.14233/ajchem.2014.15376
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-drug interaction is one of the Most important preclinical investigation directions, It may have serious impact on drug absorption, distribution and elimination through Membrane transporters, Liquid chromatography/Tandem Mass spectrometry (LC/MS/MS) Could be used to investigate drug drug interaction in vitro. A sensitive LC/MS/MS method was established for quantification of rosuvastatin in HEK293 and S2 cell lysates. Internal standard (IS) was indapamide. Detection mode was positive eleetrospray ionization. The lower limit of quantification (LLOQ) was 0.05 ng/mL. The affinity of rosuvastatin with organic anion transporting polypeptides 1B1 and 2B1 (OATP1B1 and OATP2B1) was investigated through uptake experiment, All cell samples were precipitated with methanol. Analytes were separated by reversed-phase chromatography and analyze by Tandem mass spectrometry using m/z 482.2/258.1 for rosuvastatin and m/z 366.1/132.1 for indapamide. Rosuvastatin uptake was saturable with KM value of 11.70 and 5.98 mu M for OATP1B1 and OATP2B1. Rosuvastatin could be used as a good probe for studying membrane transporter activity and drug-drug interaction through LC/MS/MS method.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [41] Therapeutic Implications of OATP1B1 Polymorphisms
    Niemi, Mikko
    DRUG METABOLISM REVIEWS, 2010, 42 : 7 - 7
  • [42] Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice
    van de Steeg, Evita
    van Esch, Anita
    Wagenaar, Els
    Kenworthy, Kathryn E.
    Schinkel, Alfred H.
    CLINICAL CANCER RESEARCH, 2013, 19 (04) : 821 - 832
  • [43] Effect of statins on OATP1B1 expression
    Duck, Zachary A.
    Wright, Stephen
    Wilkerson, Matt
    Li, Jibin
    Hidalgo, Ismael
    FASEB JOURNAL, 2013, 27
  • [44] Rifampicin Transport by OATP1B1 Variants
    Litjens, Carlijn H. C.
    van den Heuvel, Jeroen J. M. W.
    Russel, Frans G. M.
    Aarnoutse, Rob E.
    te Brake, Lindsey H. M.
    Koenderink, Jan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (10)
  • [45] 8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of Organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1
    Ungvari, Orsolya
    Kiraly, Laura
    Bakos, Eva
    Ozvegy-Laczka, Csilla
    FASEB JOURNAL, 2021, 35 (09):
  • [46] In Silico and in Vitro Assessment of OATP1B1 Inhibition in Drug Discovery
    Danielson, Matthew L.
    Sawada, Geri A.
    Raub, Thomas J.
    Desai, Prashant V.
    MOLECULAR PHARMACEUTICS, 2018, 15 (08) : 3060 - 3068
  • [47] Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3
    Lu, Yanli
    Hu, Qingqing
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    XENOBIOTICA, 2019, 49 (02) : 239 - 246
  • [48] Evaluating the In Vitro Inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in Predicting Drug-Induced Hyperbilirubinemia
    Chang, Jae H.
    Plise, Emile
    Cheong, Jonathan
    Ho, Quynh
    Lin, Molly
    MOLECULAR PHARMACEUTICS, 2013, 10 (08) : 3067 - 3075
  • [49] Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers
    Mori, Daiki
    Kashihara, Yushi
    Yoshikado, Takashi
    Kimura, Miyuki
    Hirota, Takeshi
    Matsuki, Shunji
    Maeda, Kazuya
    Irie, Shin
    Ieiri, Ichiro
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 78 - 86
  • [50] Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
    Powell, John T.
    Kayesh, Ruhul
    Ballesteros-Perez, Alexandra
    Alam, Khondoker
    Niyonshuti, Pascaline
    Soderblom, Erik J.
    Ding, Kai
    Xu, Chao
    Yue, Wei
    PHARMACEUTICS, 2024, 16 (01)